|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Vepesid (Etoposide). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (44)
Cases resulting in a serious event (44)
Cases resulting in death (24)
Cases resulting in life threatening events (14)
Cases resulting in hospitalization (14)
Cases resulting in disability (2)
Cases resulting in other serious reactions (16)
Below is a sample of reports where side effects / adverse reactions may be related to Vepesid (Etoposide). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 28 year old female receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-29
Patient: 28 year old female
Adverse reactions / side effects: Pneumonia, Acute Myeloid Leukaemia
Adverse event resulted in: death
Suspect drug(s):
Vepesid
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-04-17
End date: 2006-04-19
Endoxan
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-03-07
End date: 2006-03-07
Oncovin
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-03-06
End date: 2006-03-27
Cylocide
Dosage: cytorabine 2.7gx2 per day was given from 17-apr-2006 to 20-apr-2006 for 4 days.
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-07-10
End date: 2006-07-21
Leunase
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-03-30
End date: 2006-04-03
Other drugs received by patient: Adriamycin PFS; Methotrexate; Mercaptopurine
Adverse event in 74 year old female receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-25
Patient: 74 year old female
Adverse reactions / side effects: Interstitial Lung Disease, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Vepesid (Etoposide)
Adverse event in 28 year old female receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-22
Patient: 28 year old female
Adverse reactions / side effects: Pneumonia, Acute Myeloid Leukaemia
Adverse event resulted in: death
Suspect drug(s):
Vepesid
Indication: Acute Lymphocytic Leukaemia
Endoxan
Other drugs received by patient: Adriamycin PFS; Daunomycin; Oncovin; Cytarabine
Adverse event in 74 year old female receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-16
Patient: 74 year old female
Adverse reactions / side effects: Lung Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Vepesid (Etoposide)
Adverse event in 58 year old female receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-15
Patient: 58 year old female
Adverse reactions / side effects: Neoplasm Recurrence, Interstitial Lung Disease, Malignant Neoplasm Progression
Adverse event resulted in: death
Suspect drug(s):
Vepesid
Indication: Hepatic Mass
Adriamycin RDF
Cyclophosphamide
Administration route: Oral
Vincristine Sulfate
Cisplatin
Indication: Hepatic Mass
Fluorouracil
Administration route: Oral
Radiation Therapy
Other drugs received by patient: Randa
Adverse event in 6 year old male receiving Vepesid (Etoposide)
Reported by a physician from Japan on 2007-10-09
Patient: 6 year old male, weighing 16.0 kg (35.2 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Blood Urea Increased, Neoplasm Progression, Hypernatraemia, Pneumonia Bacterial, Respiratory Failure, Platelet Count Decreased, Bone Marrow Failure, Neutrophil Count Decreased, Lymphocyte Count Decreased, Infection
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Temodal
Dosage: 75 mg/m2; qd; po
Administration route: Oral
Indication: Brain Neoplasm
Start date: 2006-09-20
End date: 2006-10-23
Vepesid
Dosage: po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-10-07
End date: 2006-10-26
Other drugs received by patient: Baktar; Lastet S; Nasea-OD; Primperan; Decadron; Mannitol; Buprenorphine HCL; Prodif; Gammagard
Adverse event in 49 year old female receiving Vepesid (Etoposide)
Reported by a consumer/non-health professional from France on 2007-10-02
Patient: 49 year old female
Adverse reactions / side effects: Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Augmentin '125'
Dosage: 1g three times per day
Start date: 2007-04-30
End date: 2007-05-05
Vepesid
Start date: 2007-05-04
End date: 2007-05-04
Other drugs received by patient: Zofran; Cisplatin; Mannitol 10%; Omeprazole; Atarax; Solu-Medrol; Vp16; Eprex; Tramadol HCL
Adverse event in 58 year old female receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-02
Patient: 58 year old female
Adverse reactions / side effects: Neoplasm Recurrence, Interstitial Lung Disease, Malignant Neoplasm Progression
Adverse event resulted in: death
Suspect drug(s):
Briplatin
Indication: Hepatic Mass
Vepesid
Indication: Hepatic Mass
Adriamycin RDF
Cyclophosphamide
Administration route: Oral
Vincristine Sulfate
Fluorouracil
Administration route: Oral
Radiation Therapy
Other drugs received by patient: Randa
Adverse event in 8 year old male receiving Vepesid (Etoposide)
Reported by a consumer/non-health professional from Japan on 2007-07-30
Patient: 8 year old male
Adverse reactions / side effects: Ewing's Sarcoma
Suspect drug(s):
Paraplatin
Indication: Retinoblastoma Bilateral
Vepesid
Indication: Retinoblastoma Bilateral
Other drugs received by patient: Oncovin; Cyclophosphamide; Pirarubicin HCL
Adverse event in 2 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-27
Patient: 2 year old male
Adverse reactions / side effects: Bone Marrow Failure, Inappropriate Antidiuretic Hormone Secretion, Hydrocephalus, Intestinal Obstruction
Suspect drug(s):
Vepesid
Indication: Ependymoma
Start date: 2007-02-21
End date: 2007-02-22
Briplatin
Indication: Ependymoma
Start date: 2007-02-20
End date: 2007-02-20
Other drugs received by patient: Oncovin; Cyclophosphamide; Itraconazole
Adverse event in 77 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Portugal on 2007-07-24
Patient: 77 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Vomiting, Nausea, Tachycardia, Hypotension, Hepatorenal Syndrome, Urine Output Decreased, Acute Hepatic Failure, Haematemesis
Adverse event resulted in: death
Suspect drug(s):
Vepesid (Etoposide)
Other drugs received by patient: Losartan Potassium; Atorvastatin Calcium; Allopurinol; Serenoa Repens; Darbepoetin Alfa
Adverse event in 29 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-10
Patient: 29 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Disseminated Intravascular Coagulation, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Bleomycin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-04-06
End date: 2006-04-13
Paraplatin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Vepesid
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Other drugs received by patient: Randa; Kytril; Meylon; Diamox; Gran; Diprivan; Elaspol; Zantac; Morphine; Lasix; Musculax; Oxycodone HCL; Lornoxicam; Rebamipide; Fentanyl; Domperidone; Prochlorperazine Maleate
Adverse event in 21 year old male receiving Vepesid (Etoposide)
Reported by a consumer/non-health professional from United States on 2007-06-25
Patient: 21 year old male
Adverse reactions / side effects: Tumour Lysis Syndrome
Suspect drug(s):
Vepesid
Indication: Burkitt's Lymphoma
Endoxan
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Ifomide
Indication: Burkitt's Lymphoma
Vincristine Sulfate
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Adverse event in 49 year old female receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-06-22
Patient: 49 year old female
Adverse reactions / side effects: Myelodysplastic Syndrome
Adverse event resulted in: death
Suspect drug(s):
Briplatin
Indication: Ovarian Cancer
Vepesid
Administration route: Oral
Indication: Ovarian Cancer
Other drugs received by patient: Adriamycin PFS; Endoxan; Irinotecan HCL
Adverse event in 50 year old male receiving Vepesid (Etoposide)
Reported by a individual with unspecified qualification from France on 2007-06-08
Patient: 50 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Disseminated Intravascular Coagulation, Intubation, Pyrexia, Multi-Organ Failure, Cardio-Respiratory Arrest, Cardiac Massage, C-Reactive Protein Increased, Bacterial Sepsis, Bone Marrow Failure, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Decreased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Life Support, Protein Total Decreased, Respiratory Distress, Haemoglobin Decreased, Renal Failure, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Platelet Count Decreased, Septic Shock, Prothrombin Level Decreased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Vepesid
Dosage: 150 mg daily
Indication: Acute Lymphocytic Leukaemia
Purinethol
Dosage: 50 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Gleevec
Dosage: 400 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Dexamethasone 0.5mg TAB
Adverse event in 29 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-29
Patient: 29 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Disseminated Intravascular Coagulation, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Bleomycin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-04-06
End date: 2006-04-13
Paraplatin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Vepesid
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Other drugs received by patient: Randa; Kytril; Meylon; Diamox; Gran; Diprivan; Elaspol; Zantac; Morphine; Lasix; Musculax; Oxycodone HCL; Lornoxicam; Rebamipide; Fentanyl; Domperidone; Prochlorperazine Maleate
Adverse event in 29 year old male receiving Vepesid (Etoposide)
Reported by a physician from Japan on 2007-05-29
Patient: 29 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Disseminated Intravascular Coagulation, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Paraplatin
Indication: Germ Cell Cancer
Start date: 2006-05-09
End date: 2006-05-13
Vepesid
Indication: Germ Cell Cancer
Start date: 2006-05-09
End date: 2006-05-13
Other drugs received by patient: Oxycodone HCL; Lornoxicam; Rebamipide; Fentanyl; Domperidone; Prochlorperazine Maleate
Adverse event in 29 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-25
Patient: 29 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Disseminated Intravascular Coagulation, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Bleomycin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-04-06
End date: 2006-04-13
Paraplatin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Vepesid
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Other drugs received by patient: Randa; Kytril; Meylon; Diamox; Gran; Diprivan; Elaspol; Zantac; Morphine; Lasix; Musculax
Adverse event in 21 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-22
Patient: 21 year old male
Adverse reactions / side effects: Tumour Lysis Syndrome
Suspect drug(s):
Vepesid
Indication: Burkitt's Lymphoma
Endoxan
Methotrexate
Ifomide
Vincristine Sulfate
Doxorubicin HCL
ARA-C
Adverse event in 77 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Portugal on 2007-05-16
Patient: 77 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Vomiting, Nausea, Tachycardia, Hypotension, Hepatorenal Syndrome, Urine Output Decreased, Acute Hepatic Failure, Haematemesis
Adverse event resulted in: death
Suspect drug(s):
Vepesid (Etoposide)
Other drugs received by patient: Losartan Potassium; Atorvastatin Calcium; Allopurinol; Serenoa Repens; Darbepoetin Alfa
Adverse event in 29 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-16
Patient: 29 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Disseminated Intravascular Coagulation, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Bleomycin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-04-06
End date: 2006-04-13
Paraplatin
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Vepesid
Indication: Malignant Mediastinal Neoplasm
Start date: 2006-05-09
End date: 2006-05-13
Other drugs received by patient: Randa; Kytril; Meylon; Diamox; Gran; Diprivan; Elaspol; Zantac; Morphine; Lasix; Musculax
Adverse event in 29 year old male receiving Vepesid (Etoposide)
Reported by a physician from Japan on 2007-05-09
Patient: 29 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Disseminated Intravascular Coagulation, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Paraplatin
Indication: Germ Cell Cancer
Start date: 2006-05-09
End date: 2006-05-13
Vepesid
Indication: Germ Cell Cancer
Start date: 2006-05-09
End date: 2006-05-13
Other drugs received by patient: Oxycodone HCL; Lornoxicam; Rebamipide; Fentanyl; Domperidone; Prochlorperazine Maleate
Adverse event in 64 year old female receiving Vepesid (Etoposide)
Reported by a physician from United States on 2007-05-08
Patient: 64 year old female
Adverse reactions / side effects: Malignant Neoplasm Progression
Adverse event resulted in: death
Suspect drug(s):
Vepesid (Etoposide)
Other drugs received by patient: Dexamethasone 0.5mg TAB; Lorazepam; Oxycodone HCL; Radiation Therapy
Adverse event in 30 year old male receiving Vepesid (Etoposide)
Reported by a consumer/non-health professional from France on 2007-05-08
Patient: 30 year old male
Adverse reactions / side effects: Vomiting, Chest Pain, Electrocardiogram Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Bleomycine Roger Bellon
Indication: Testis Cancer
Start date: 2007-02-06
End date: 2007-02-06
Vepesid
Indication: Testis Cancer
Start date: 2007-01-29
End date: 2007-02-02
Cisplatin
Indication: Testis Cancer
Start date: 2007-01-29
End date: 2007-02-02
Other drugs received by patient: Epoetin Beta; Zofran; Solu-Medrol; Polaramine
Adverse event in 77 year old male receiving Vepesid (Etoposide)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-04-24
Patient: 77 year old male
Adverse reactions / side effects: Malignant Neoplasm Progression, Lymphoma
Adverse event resulted in: death
Suspect drug(s):
Vepesid
Administration route: Oral
Indication: Prostate Cancer
Start date: 1998-09-28
End date: 2003-09-10
Estracyt
Administration route: Oral
Indication: Prostate Cancer
Start date: 1998-09-28
End date: 2003-09-10
Other drugs received by patient: Selbex; BUP-4
|
